IP Library Granted Patent US 11,676,694
Granted Patent B2
US 11,676,694 · App. 16/846,908 · Granted Jun 13, 2023

Device and method for training users of ambulatory medical devices

Inventors: Geoffrey A. Kruse (San Diego, CA); Kim Blickenstaff (San Diego, CA); Michael J. Rosinko (Anaheim, CA)
Assignee: Tandem Diabetes Care, Inc.
G16H20/17A61M5/1413A61M5/14244A61M5/172A61M5/1723A61M2205/502A61M2205/505A61M2205/52A61M2230/005A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,676,694
App. No.
16/846,908
Granted
Jun 13, 2023
Kind
B2
Abstract

Apparatuses and methods for training users of ambulatory medical devices. The methods relate to improving user interactions with the touchscreens of devices. In one embodiment there is an operating mode that records all user interactions along with various device parameters and allows the clinician to review the patient's performance for the initial use period. Automated analysis software may be employed to analyze the data generated by the device. The results of the analysis may be used by the clinician to improve the patient and device interaction.

Claims (29)

1. A method of improving a user's treatment of diabetes, comprising:

receiving parameters relating to programming and operation of an ambulatory infusion pump;

receiving glucose level data of the user;

analyzing the parameters relating to the user's programming and operation of the ambulatory infusion pump and the glucose level data with automated analysis software in real-time as the user is operating the ambulatory infusion pump;

identifying with the automated analysis software one or more trends in user operation of the device based on the analysis; and

providing user-specific recommendations based on the user's lifestyle for improving treatment of the user based on the one or more trends.

2. The method of claim 1 , wherein analyzing the parameters relating to programming and operation of the ambulatory infusion pump includes analyzing insulin dosages delivered to the user.

3. The method of claim 1 , wherein the automated analysis software further analyzes data relating to a physical state of the user in identifying the one or more trends.

4. The method of claim 1 , wherein receiving glucose level data of the user includes receiving the glucose level data from a continuous glucose monitor.

5. The method of claim 1 , wherein providing user-specific recommendations for improving treatment of the user based on the one or more trends includes providing the user-specific recommendations on a display.

6. The method of claim 5 , wherein providing the user-specific recommendations on a display includes providing the recommendations on a display of a smartphone.

7. The method of claim 1 , further comprising transferring the parameters relating to the user's programming and operation of the ambulatory infusion pump and the glucose level data to a separate device and wherein the automated analysis software resides on the separate device.

8. The method of claim 1 , wherein the one or more trends in user operation of the device identified based on the analysis includes one or more errors where user operation does not match caregiver instructions.

9. The method of claim 1 , wherein the one or more trends in user operation of the device identified based on the analysis includes one or more difficulties where user operation deviates significantly from an optimum path for operation of the ambulatory infusion pump.

10. The method of claim 1 , wherein the user-specific recommendations for improving treatment of the user based on the one or more trends include recommendations for changing settings of the ambulatory infusion pump.

11. A method of improving a user's treatment of diabetes, comprising:

receiving information pertaining to a user's treatment of diabetes, the information including glucose levels of the user;

analyzing the information pertaining to the user's treatment of diabetes with automated analysis software in real-time as the information pertaining to the user's treatment of diabetes is received;

identifying with the automated analysis software one or more areas where the user can improve treatment of the user based on the analysis; and

providing user-specific recommendations based on the user's lifestyle for improving treatment of the user based on the one or more areas.

12. The method of claim 11 , wherein the automated analysis software further analyzes insulin dosages delivered to the user in identifying the one or more areas where the user can improve treatment of the user.

13. The method of claim 11 , wherein the automated analysis software further analyzes data relating to a physical state of the user in identifying the one or more areas where the user can improve treatment of the user.

14. The method of claim 11 , further comprising receiving the glucose levels of the user from a continuous glucose monitor.

15. The method of claim 11 , wherein providing user-specific recommendations for improving treatment of the user based on the one or more areas includes providing the user-specific recommendations on a display.

16. The method of claim 15 , wherein providing the user-specific recommendations on a display includes providing the recommendations on a display of a smartphone.

17. The method of claim 11 , further comprising transferring the information pertaining to the user's treatment of diabetes to a separate device and wherein the automated analysis software resides on the separate device.

18. The method of claim 11 , wherein the one or more areas where the user can improve treatment identified based on the analysis includes one or more errors where user operation does not match caregiver instructions.

19. The method of claim 11 , wherein the one or more areas where the user can improve treatment identified based on the analysis includes one or more difficulties where user operation deviates significantly from an optimum path for operation of the ambulatory infusion pump.

20. The method of claim 11 , wherein the user-specific recommendations for improving treatment of the user based on the one or more areas include recommendations for changing settings of an ambulatory infusion pump.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: KRUSE, GEOFF; BLICKENSTAFF, KIM; ROSINKO, MIKE
To: TANDEM DIABETES CARE, INC.
Reel/Frame 052379/0911 →